Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Placebo Controlled Randomized Clinical Trial of Pregabalin for Alcohol Dependence

NCT02205879 is registered in ClinicalTrials.gov with St. Petersburg Bekhterev Research Psychoneurological Institute as lead sponsor.

NCT NCT02205879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Placebo Controlled Randomized Clinical Trial of Pregabalin for Alcohol Dependence
Lead sponsor
St. Petersburg Bekhterev Research Psychoneurological Institute
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism